Market Research Logo

Active Pharmaceutical Ingredient Market by type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Therapy (Oncology, diabetes, Orthopedic, CNS, Nephrology, Ophthalmology) - Global Forecast to 2020

Active Pharmaceutical Ingredient Market by type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Therapy (Oncology, diabetes, Orthopedic, CNS, Nephrology, Ophthalmology) - Global Forecast to 2020

The Active Pharmaceutical Ingredients market is categorized on the basis of type, type of manufacturer, type of synthesis, therapeutic area and region. Factors such as increasing incidence of life style and age related diseases, Increasing prevalence of cancer across the world, Technological advancements in the APIs Manufacturing, Emerging markets for biosimilars and increasing scope for Highly potent active ingredients are driving market growth. On the other hand, stringent regulatory guidelines and global economic recession may restrict market growth in the forecast period.

North America accounts for the highest share of the global APIs market. The overall technological advancements in this region coupled with factors like increase in lifestyle and age related disorders in this region, the increase in demand for specialty biological and specialty drugs and increasing government focus on generics following the implementation of the Patient Protection and Affordable Care Act is driving the growth of this market.

Apart from the comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, and change in strategic approach; R&D investments; and levels of output in order to remain successful.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of top players in the APIs market. The report analyzes the APIs and HPAPIs market by type, type of synthesis, type of manufacturer, therapeutic area and region.
Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the APIs market
Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in APIs market
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for APIs across geographies
Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the APIs market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • LIMITATIONS
    • CURRENCY
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP DOWN APPROACH
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS AND LIMITATIONS
      • ASSUMPTIONS
      • LIMITATIONS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
    • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC AREA
    • ACTIVE PHARMACEUTICAL INGREDIENTS, BY TYPE OF SYNTHESIS
    • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER
    • GEOGRAPHIC SNAPSHOT OF THE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
    • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
    • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS
    • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER
    • GEOGRAPHIC SNAPSHOT OF THE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
      • BY TYPE
      • MARKET SEGMENTATION, BY TYPE OF SYNTHESIS
      • MARKET SEGMENTATION, BY TYPE OF MANUFACTURER
      • MARKET SEGMENTATION, BY THERAPEUTIC AREA
      • MARKET SEGMENTATION, BY REGION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY SYNTHESIS
    • Table GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
    • SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS
      • Table GLOBAL SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
      • Table NORTH AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table ASIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
      • SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY TYPE
        • Table GLOBAL SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
      • BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS
        • Table GLOBAL BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
        • Table GLOBAL BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
        • Table GLOBAL BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER
    • INTRODUCTION
      • Table GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2013-2020 (USD BILLION)
    • CAPTIVE API MANUFACTURERS
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR CAPTIVE MANUFACTURERS, BY REGION, 2013-2020 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR CAPTIVE MANUFACTURERS, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR CAPTIVE MANUFACTURERS, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR CAPTIVE MANUFACTURERS, BY COUNTRY, 2013-2020 (USD BILLION)
    • MERCHANT API MANUFACTURERS
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR MERCHANT MANUFACTURERS, BY REGION, 2013-2020 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR MERCHANT MANUFACTURERS, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR MERCHANT MANUFACTURERS, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR MERCHANT MANUFACTURERS, BY COUNTRY, 2013-2020 (USD BILLION)
      • MERCHANT API MANUFACTURERS MARKET, BY TYPE
        • Table GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR MERCHANT MANUFACTURERS, BY TYPE, 2013-2020 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
    • INTRODUCTION
      • Table GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
    • INNOVATIVE APIS SEGMENT
      • Table PATENTS EXPIRIES, 2015
    • GENERIC APIS SEGMENT
      • Table GLOBAL GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC AREA
    • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD BILLION)
    • ONCOLOGY
      • Table CANCER: ESTIMATED INCIDENCE, MORTALITY, AND PREVALENCE (2012)
    • DIABETES
      • Table REGIONAL ESTIMATES FOR DIABETES (2013)
    • CARDIOVASCULAR DISEASE
    • CNS AND NEUROLOGICAL DISORDERS
    • ORTHOPEDIC DISORDERS
    • NEPHROLOGY
    • OPHTHALMOLOGY
    • PULMONOLOGY
      • Table U.S.: LEADING RESPIRATORY DRUGS, 2014
    • GASTROINTESTINAL DISORDERS
    • ENDOCRINOLOGY
  • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
    • INTRODUCTION
      • Table GLOBAL HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
      • Table NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • HPAPI CLASSIFICATION
      • OVERVIEW: HPAPI GLOBAL MARKET
      • MANUFACTURING CAPABILITIES
    • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT
      • HPAPI MARKET, BY TYPE
        • Table GLOBAL HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table GLOBAL GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
        • Table NORTH AMERICA: GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
        • Table EUROPE: GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
        • Table ASIA: GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
    • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER
      • Table GLOBAL HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2013-2020 (USD BILLION)
      • Table GLOBAL CAPTIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
      • Table NORTH AMERICA: CAPTIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table EUROPE: CAPTIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table ASIA: CAPTIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table GLOBAL MERCHANT HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
      • Table NORTH AMERICA: MERCHANT HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table EUROPE: MERCHANT HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table ASIA: MERCHANT HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table GLOBAL MERCHANT HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
    • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY METHOD OF SYNTHESIS
      • Table GLOBAL HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • Table GLOBAL SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
      • Table NORTH AMERICA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table EUROPE: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table ASIA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table GLOBAL SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
      • Table GLOBAL BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
      • Table NORTH AMERICA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table EUROPE: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table ASIA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table GLOBAL BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
    • PEST ANALYSIS
      • POLITICAL FACTORS
      • ECONOMICAL FACTORS
      • SOCIAL FACTORS
      • TECHNOLOGICAL FACTORS
    • NORTH AMERICA
      • NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
      • NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • U.S.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table U.S.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table U.S.: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • U.S.: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table U.S.: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • CANADA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table CANADA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
    • EUROPE
      • EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
      • EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • U.K.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table U.K.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table U.K.: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
      • U.K.: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table U.K.: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • FRANCE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table FRANCE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • GERMANY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table GERMANY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • SPAIN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table SPAIN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • ITALY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table ITALY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table ROE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • ROE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table ROE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
    • ASIA
      • ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
      • ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • INDIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table INDIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • JAPAN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table JAPAN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • SOUTH KOREA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table SOUTH KOREA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • CHINA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table CHINA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
      • ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
        • Table ROA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • ROA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table ROA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2013-2020 (USD BILLION)
    • ROW
      • ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table ROW: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
      • ROW: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
        • Table ROW: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
  • COMPETITIVE LANDSCAPE
    • COMPETITIVE SITUATION AND TRENDS
      • NEW PRODUCT LAUNCHES
        • Table NEW PRODUCT LAUNCHES
      • MERGERS AND ACQUISITIONS
        • Table MERGERS AND ACQUISITIONS
      • PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES
        • Table PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES
      • EXPANSION
        • Table EXPANSIONS
  • COMPANY PROFILES
    • INTRODUCTION
    • TEVA PHARMACEUTICAL INDUSTRIES LIMITED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DR. REDDY'S LABORATORIES LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SUN PHARMACEUTICAL INDUSTRIES LTD.
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • AUROBINDO PHARMA LTD.
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NOVARTIS INTERNATIONAL AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ALBEMARLE CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • SIGMA-ALDRICH CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MYLAN INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ALLERGAN PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • BOEHRINGER INGELHEIM
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS FROM INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • OTHER DEVELOPMENTS, BY COMPANY, 2012-2015
      • Table SUN PHARMACEUTICALS INDUSTRIES LTD.
      • Table TEVA PHARMACEUTICAL INDUSTRIES LIMITED
      • Table DR. REDDY'S LABORATORIES
      • Table AUROBINDO PHARMA
      • Table NOVARTIS
      • Table BOEHRINGER INGELHEIM
      • Table ALBEMARLE CORPORATION
      • Table SIGMA-ALDRICH
      • Table MYLAN INC.
      • Table ALLERGAN PLC.
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report